Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 18

1.

Inhibitory effects of 90Sr/90Y β-irradiation on alkali burn-induced corneal neovascularization in rats.

Lin Y, Ma Q, Lin S, Zhou H, Wen Q, Gao S, Cheng G.

Exp Ther Med. 2016 Feb;11(2):409-414. Epub 2015 Dec 2.

2.

Clinical correlates of common corneal neovascular diseases: a literature review.

Abdelfattah NS, Amgad M, Zayed AA, Salem H, Elkhanany AE, Hussein H, Abd El-Baky N.

Int J Ophthalmol. 2015 Feb 18;8(1):182-93. doi: 10.3980/j.issn.2222-3959.2015.01.32. eCollection 2015. Review.

3.
4.

Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization.

Wang Q, Yang J, Tang K, Luo L, Wang L, Tian L, Jiang Y, Feng J, Li Y, Shen B, Lv M, Huang Y.

BMC Biotechnol. 2014 Feb 27;14:17. doi: 10.1186/1472-6750-14-17.

5.

Effect of thalidomide on the expression of vascular endothelial growth factor in a rat model of liver regeneration.

Hung KC, Hsieh PM, Yang KL, Lin KJ, Chen YS, Hung CH.

Oncol Lett. 2013 Mar;5(3):852-856. Epub 2012 Dec 20.

7.

Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis.

Chen YY, Yen HH, Chou KC, Wu SS.

World J Gastroenterol. 2012 Feb 7;18(5):466-71. doi: 10.3748/wjg.v18.i5.466.

8.

Angiogenesis in head and neck cancer: a review of the literature.

Carla C, Daris F, Cecilia B, Francesca B, Francesca C, Paolo F.

J Oncol. 2012;2012:358472. doi: 10.1155/2012/358472. Epub 2011 Nov 10.

9.
10.

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK.

Hepatol Int. 2010 Mar 18;4(2):439-74. doi: 10.1007/s12072-010-9165-7.

11.
12.

Novel aspects of corneal angiogenic and lymphangiogenic privilege.

Ellenberg D, Azar DT, Hallak JA, Tobaigy F, Han KY, Jain S, Zhou Z, Chang JH.

Prog Retin Eye Res. 2010 May;29(3):208-48. doi: 10.1016/j.preteyeres.2010.01.002. Epub 2010 Jan 25. Review.

13.

Antiangiogenic therapy in brain tumors.

Lakka SS, Rao JS.

Expert Rev Neurother. 2008 Oct;8(10):1457-73. doi: 10.1586/14737175.8.10.1457. Review.

14.
15.

A pilot study of antiangiogenic therapy with bevacizumab and thalidomide in patients with metastatic renal cell carcinoma.

Elaraj DM, White DE, Steinberg SM, Haworth L, Rosenberg SA, Yang JC.

J Immunother. 2004 Jul-Aug;27(4):259-64.

16.

Thalidomide and its derivatives: emerging from the wilderness.

Gordon JN, Goggin PM.

Postgrad Med J. 2003 Mar;79(929):127-32. Review.

17.
18.

Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.

Arrieta O, Guevara P, Tamariz J, Rembao D, Rivera E, Sotelo J.

Int J Exp Pathol. 2002 Apr;83(2):99-104.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk